| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |